Marpai authorizes Series A preferred stock
Marpi authorized 12,100 shares of Series A Convertible Preferred Stock, valuing its capital structure. The departure from the stock automatically converts to common shares.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Marpi authorized 12,100 shares of Series A Convertible Preferred Stock, valuing its capital structure. The departure from the stock automatically converts to common shares.
CDT Equity Inc filed an exhibit with the SEC regarding Common Stock Purchase Warrants. The document details terms for the purchase of up to hundreds of thousands of shares of Commo…
The company agreed to sell common stock to investors at $1.25 per share, with the transaction exempt from registration, for an aggregate Purchase Price of $[*].
Catheter Precision's board has designated rights for up to 80,000 shares of Series C-4 convertible preferred stock, with 33,158 shares currently outstanding, due to raise capital.
BigBear.ai Holdings has executed a share sales agreement with Jefferies LLC, allowing the sale of up to 100 million shares of common stock. The offering is conducted under a curren…
Healthcare Realty Trust has engaged Venable to provide Maryland legal counsel for the company's registration statement allowing for up to $1 billion in common stock sales via at-th…
Clean Energy Technologies, Inc. entered into a securities purchase agreement with 1800 Diagonal Lending LLC to issue and sell promissory notes in the aggregate principal amount of …
CenterPoint Energy Inc. priced $700 million of 6.400% Fixed-to-Fixed Reset Rate Junior Subordinated Notes Series E due 2058, pursuant to an Underwriting Agreement dated July 30, 20…
Synchrony Financial priced $600M of 5.450% notes due 2030 and $500M of 6.276% notes due 2037, underwritten by J.P. Morgan, TD Securities, and Wells Fargo.
VSee Health agrees to sell a convertible promissory note with a $336,000 principal amount and $300,000 purchase price to Labrys Fund II on June 30, 2026, for legal and due diligenc…
The trust will separate its Class A ordinary shares and redeemable warrants for independent trading on the Nasdaq Global Market starting August 3, 2026. This corporate action is re…
The SPAC issued a $50 million promissory note to Lender with a maturity date in 2029. The note allows for interest-free loans determined by the lender, distinguishing Armada from S…
The cannabis company filed its bylaws and a certificate designating a series of preferred stock, typically to raise capital or grant special voting rights.
Special counsel issued an opinion regarding Form S-3 and a prospectus supplement related to the issuance of up to 920,000 shares of common stock.
Special counsel has rendered an opinion regarding the validity of up to 2,499,567 Class A common stock shares in a Form S-3 filing, intended for an unspecified number of IBG Holdin…
NOMAD Power Solutions announced options trading for its NMAD stock on the CBOE exchange, aiming to enhance liquidity and investor participation.
Co-Diagnostics Inc. has entered into a placement agency agreement with Maxim Group LLC. Under this agreement, Maxim will act as the exclusive placement agent to sell Common Stock, …
Beyond Air issued Pre-Funded Warrants to purchase Common Stock at a nominal exercise price to investors for good and valuable consideration. The converts like the personal fraud I …
Pelican Acquisition II Corp agreed to sell 7.5 million units, each priced at the public offering price of $10.00, in a deal led by EarlyBirdCapital. The deal supports the company's…
Inovio Pharmaceuticals priced an offering of 21.1 million shares of common stock and warrants for 42.1 million shares. The move is a capital raise intended to fund ongoing operatio…